GENOMIC HEALTH INC (GHDX) is a publicly traded company in the Unknown sector. Across all available filings, 25 corporate insiders have executed 1000 transactions totaling $403.7M, demonstrating a bearish sentiment with -$403.7M in net insider flow. The most recent transaction on Nov 8, 2019 involved a purchase of 37,643,330 shares valued at $0.
No significant insider buying has been recorded for GHDX in the recent period.
No significant insider selling has been recorded for GHDX in the recent period.
Based on recent SEC filings, insider sentiment for GHDX is bearish with an Insider Alignment Score of 0/100 and a net flow of -$403.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at GENOMIC HEALTH INC (GHDX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 25 insiders are actively trading GHDX stock, having executed 1000 transactions in the past 90 days. The most active insider is L.p. 14159, (Executive), who has made 78 transactions totaling $54.6M.
Get notified when executives and directors at GHDX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 8, 2019 | Corp Exact Sciences | Executive | Purchase | 37,643,330 | $N/A | $0 | |
| Nov 8, 2019 | J. Popovits Kimberly | Executive | Disposition | 36,168 | $N/A | $0 | |
| Nov 8, 2019 | J. Popovits Kimberly | Executive | Disposition | 68,268 | $N/A | $0 | |
| Nov 8, 2019 | J. Popovits Kimberly | Executive | Disposition | 12,298 | $N/A | $0 | |
| Nov 8, 2019 | Bradley Cole G. | Executive | Disposition | 11,794 | $N/A | $0 | |
| Nov 8, 2019 | Bradley Cole G. | Executive | Disposition | 27,385 | $N/A | $0 | |
| Nov 8, 2019 | Shak Steven | Executive | Disposition | 9,210 | $N/A | $0 | |
| Nov 8, 2019 | Shak Steven | Executive | Disposition | 49,585 | $N/A | $0 | |
| Nov 8, 2019 | Pla Frederic | Executive | Disposition | 18,510 | $N/A | $0 | |
| Nov 8, 2019 | J. Vaughn James | Executive | Disposition | 5,249 | $N/A | $0 | |
| Nov 8, 2019 | W. Radford Jason | Executive | Disposition | 20,924 | $N/A | $0 | |
| Nov 8, 2019 | W. Radford Jason | Executive | Disposition | 8,384 | $N/A | $0 | |
| Nov 8, 2019 | Hoof Torsten | Executive | Disposition | 10,388 | $N/A | $0 | |
| Nov 8, 2019 | Hoof Torsten | Executive | Disposition | 4,479 | $N/A | $0 | |
| Nov 8, 2019 | Mceachron Kim | Executive | Disposition | 25,293 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 804 | $403.7M | 94.0% |
Exercise(M) | 88 | $22.2M | 5.2% |
Payment(F) | 8 | $2.9M | 0.7% |
Award(A) | 56 | $673.0K | 0.2% |
Purchase(P) | 1 | $0 | 0.0% |
Disposition(D) | 27 | $0 | 0.0% |
Gift(G) | 12 | $0 | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider selling pressure at GENOMIC HEALTH INC has increased, with 25 insiders executing 1000 transactions across all time. Total sales of $403.7M significantly outpace purchases of $0, resulting in a net outflow of $403.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.